NASDAQ NMS - GLOBAL MARKET · CRNX
-0.05% · -$0.0400 · Vol 7.4M
Market closed · last close 4:00 PM ET · price as of 16:53:35 ET
Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc

Pharmaceuticals
$83.58
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

Score not reportedVeridion does not publish a score-history trend for CRNX until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
NO SCORE SNAPSHOT COVERAGE
AI Analysis
Sovereign

Why is CRNX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for CRNX are being assembled.
About Crinetics Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2018
Employees
594
Country
US

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$83.61
Day high
$83.76
Day low
$83.58
Previous close
$83.62
52W high
$83.76
-0.21% from high
52W low
$83.56
10% of range
Market cap
$8.8B
Shares out
105.8M
Volume
7.4M
VWAP
$83.64
Price history computed in-house
SMA 50 $83.57 · above
SMA 200 $83.57 · above
52W position 10%
Veridion warehouse edge

Warehouse intelligence for CRNX.

Veridion Score
Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

CRNX insider activity

Crinetics Pharmaceuticals Inc

Score
Coverage building
Pressure
Net selling
Filings
37
Buys / sells
13 / 24
Net value
-$5.5M
Insiders
9
Named filers
VR
Vivaldi Coelho Rogerio
Insider
Leadership
OS
Okey Stephanie
Insider
Leadership
KE
Knight Jeff E.
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$5.5M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-07-072026-07-02Vivaldi Coelho RogerioInsidersell$40.003,00019,225$120KSEC Form 4
2026-06-182026-06-17Okey StephanieInsidersell$36.226086,400$22KSEC Form 4
2026-06-182026-06-17Okey StephanieInsidersell$35.626,2927,008$224KSEC Form 4
2026-04-102026-04-08Knight Jeff E.Insidersell$40.1085,163105,289$3.4MSEC Form 4
2026-04-102026-04-08Knight Jeff E.Insiderbuy$19.6419,336190,452$380KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 32 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

CRNX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CRNX in this window.
Lobbying spend

CRNX lobbying filings, year to date.

Registered lobbying filings matched to Crinetics Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CRNX in this window.
Latest news · CRNX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for CRNX.
Options
Sovereign unlock shows live options positioning for CRNX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.